Document:

Exhibit 10.50

 

ADDENDUM TO ADMINISTRATIVE SERVICES AGREEMENT

 

This Addendum (the “Addendum”) is entered into effective as of January 1, 2012, by and between NORTH CAROLINA RADIATION THERAPY MANAGEMENT SERVICES, LLC., a North Carolina limited liability company (“MANAGEMENT SERVICES”) and RADIATION THERAPY ASSOCIATES OF WESTERN NORTH CAROLINA, P.A., a North Carolina professional corporation (the “PA”). This Addendum amends Section 3.1 of the Administrative Services Agreement dated January 1, 2002 between the parties (the “Agreement”) to adjust the monthly Service Fee payable at the rate of $635.00 per external beam treatment billed as paid in 2011 to a monthly Service Fee payable at the rate of $600.00 per external beam treatment billed (currently CPT codes 77372, 77373, 77401 — 77416, 77418 and 77781-77784) and replaces the Addendum of that same Section dated January 1, 2011. The parties acknowledge that Management Services neither provides direct marketing services currently under the Agreement nor does this Amendment provide for Management Services to provide direct marketing services.

 

From and after the date hereof, Section 3.1 shall read as follows:

 

3.1. Service Fee.  For the services to be provided hereunder by MANAGEMENT SERVICES, the PC shall pay to MANAGEMENT SERVICES a monthly Service Fee at the rate of $600.00 per external beam treatment billed (currently CPT codes 77372, 77373, 77401 — 77416, 77418 and 77781-77784). The parties agree that the Service Fee represents the fair market value of the services provided by MANAGEMENT SERVICES hereunder and that the parties shall meet annually to reevaluate the value of services provided by MANAGEMENT SERVICES and shall establish the fair market value thereof for purposes of this Section 3.1.

 

 

	
Accepted:
    	
NORTH   CAROLINA RADIATION THERAPY
    
	
 
    	
MANAGEMENT   SERVICES, INC.
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ BRYAN J. CAREY
    
	
 
    	
 
    	
Bryan J. Carey
    
	
 
    	
 
    	
Vice President
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
Accepted:
    	
RADIATION   THERAPY ASSOCIATES OF 
    
	
 
    	
WESTERN   NORTH CAROLINA, P.A.
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ DANIEL E. DOSORETZ, M.D.
    
	
 
    	
 
    	
Daniel E. Dosoretz, M.D.
    
	
 
    	
 
    	
Vice PresidentExhibit 10.119

 

SUPPLEMENT No. 13 dated as of September 29, 2011 to the Guaranty and Collateral Agreement (the “Collateral Agreement”) dated as of February 21, 2008, among RADIATION THERAPY SERVICES HOLDINGS, INC., a Delaware corporation (“Parent”), RADIATION THERAPY SERVICES, INC., a Florida corporation (“Borrower”), each subsidiary of Borrower listed on Schedule I thereto (each such subsidiary individually a “Subsidiary Guarantor” and collectively, the “Subsidiary Guarantors”); the Subsidiary Guarantors and Borrower are referred to collectively herein as the “Grantors”) and WELLS FARGO BANK, NATIONAL ASSOCIATION (as successor to WACHOVIA BANK, NATIONAL ASSOCIATION), (“Wells”), as Collateral Agent (in such capacity, the “Collateral Agent”).

 

A.          Reference is made to the Credit Agreement dated as of February 21, 2008 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), among Parent, Borrower, the lenders from time to time party thereto, Wells, as Administrative Agent and the other financial institutions party thereto.

 

B.          Capitalized terms used in this Agreement and not otherwise defined in this Agreement shall have the meanings assigned to such terms in the Credit Agreement and the Collateral Agreement referred to therein.

 

C.          The Grantors have entered into the Collateral Agreement in order to induce the Lenders to make Loans and the Issuing Bank to issue Letters of Credit. Section 7.14 of the Collateral Agreement provides that additional Subsidiaries of Borrower may become Subsidiary Guarantors under the Collateral Agreement by execution and delivery of an instrument in the form of this Supplement. The undersigned Subsidiary (the “New Subsidiary”) is executing this Supplement in accordance with the requirements of the Credit Agreement to become Subsidiary Guarantors under the Collateral Agreement in order to induce the Lenders to make additional Loans and the Issuing Bank to issue additional Letters of Credit and as consideration for Loans previously made and Letters of Credit previously issued.

 

Accordingly, the Collateral Agent and the New Subsidiary agree as follows:

 

SECTION 1.  In accordance with Section 7.14 of the Collateral Agreement, the New Subsidiary by its signature below becomes a Subsidiary Guarantor and a Grantor under the Collateral Agreement with the same force and effect as if originally named therein as a Subsidiary Guarantor and a Grantor and the New Subsidiary hereby (a) agrees to all the terms and provisions of the Collateral Agreement applicable to it as a Subsidiary Guarantor and Grantor thereunder and (b) represents and warrants that the representations and warranties made by it as a Grantor and Subsidiary Guarantor thereunder are true and correct on and as of the date hereof.  In furtherance of the foregoing, the New Subsidiary, as security for the payment and performance in full of the Secured Obligations (as defined in the Collateral Agreement), does hereby create and grant to the Collateral Agent, its successors and assigns, for the benefit of the Secured Parties, their successors and assigns, a security interest in and lien on all the New Subsidiary’s right, title and interest in and to the Collateral (as defined in the Collateral Agreement) of the New Subsidiary. Each reference to a “Subsidiary Guarantor” or “Grantor” in the Collateral Agreement shall be deemed to include the New Subsidiary. The Collateral Agreement is hereby incorporated in this Agreement by reference.

 

1

 

SECTION 2.   The New Subsidiary represents and warrants to the Collateral Agent and the other Secured Parties that this Supplement has been duly authorized, executed and delivered by it and constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms.

 

SECTION 3.   This Supplement may be executed in counterparts, each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Supplement shall become effective when the Collateral Agent shall have received a counterpart of this Supplement that bears the signature of the New Subsidiary and the Collateral Agent has executed a counterpart hereof. Delivery of an executed signature page to this Supplement by facsimile transmission or Adobe PDF email shall be as effective as delivery of a manually signed counterpart of this Supplement.

 

SECTION 4.   The New Subsidiary hereby represents and warrants that set forth (a) under its signature hereto is (i) the true and correct legal name of the New Subsidiary, (ii) its jurisdiction of formation, (iii) its Federal Taxpayer Identification Number and its organizational identification number and (iv) the location of its chief executive office and (b) on Schedule I hereto all Capital Stock, Instruments, Copyright, Patent and Trademark registrations, applications and licenses owned by such New Subsidiary.

 

SECTION 5.   Except as expressly supplemented hereby, the Collateral Agreement shall remain in full force and effect.

 

SECTION 6.  THIS SUPPLEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

 

SECTION 7.   Any provision of this Supplement held to be invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the remaining provisions hereof and in the Collateral Agreement; the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction. The parties shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions.

 

SECTION 8.   All communications and notices hereunder shall be in writing and given as provided in Section 7.01 of the Collateral Agreement.

 

SECTION 9.   The New Subsidiary agrees to reimburse the Collateral Agent for its reasonable out-of-pocket expenses in connection with this Supplement, including the reasonable fees, other charges and disbursements of counsel for the Collateral Agent.

 

2

 

IN WITNESS WHEREOF, the New Subsidiary and the Collateral Agent have duly executed this Supplement to the Collateral Agreement as of the day and year first above written.

 

	
 
    	
21ST   CENTURY ONCOLOGY SERVICES, INC.
    
	
 
    	
 
    

 

	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/   Bryan J. Carey
    
	
 
    	
 
    	
Name:   
    	
Bryan   J. Carey
    
	
 
    	
 
    	
Title:   
    	
Interim   Vice President
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Legal   Name:  21st Century Oncology Services, Inc.
    
	
 
    	
 
    	
Federal   Tax ID:  45-3456866
    
	
 
    	
 
    	
State   Org. ID:  5037513 
    
	
 
    	
 
    	
Jurisdiction   of Formation:  Delaware 
    
	
 
    	
 
    	
Location   of Chief Executive Office:
    
	
 
    	
 
    	
 
    	
1010   Northern Blvd., Suite 134
    
	
 
    	
 
    	
 
    	
Great   Neck, NY 11021
    
					

 

[RTS - Supplement to Collateral Agreement]

 

 

	
 
    	
WELLS   FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
    
	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/   Kent Davis
    
	
 
    	
 
    	
Name:   
    	
Kent   Davis
    
	
 
    	
 
    	
Title:   
    	
Managing   Director
    

 

[RTS - Supplement to Collateral Agreement]

 

 

Schedule I

to the Supplement No. 13
 to the Collateral Agreement

 

CAPITAL STOCK

 

	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
Number and
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Number of
    	
 
    	
Registered
    	
 
    	
Class of
    	
 
    	
Percentage of
    	
 
    
	
Issuer
    	
 
    	
Certificate
    	
 
    	
Owner
    	
 
    	
Capital Stock
    	
 
    	
Ownership
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
21st   Century Oncology Services, Inc.
    	
 
    	
None.
    	
 
    	
Radiation   Therapy Services, Inc. 
    	
 
    	
None.
    	
 
    	
100
    	
%
    

 

DEBT SECURITIES

 

	
 
    	
 
    	
Principal
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
Issuer
    	
 
    	
Amount
    	
 
    	
Date of Note
    	
 
    	
Maturity Date
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
None.
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

INTELLECTUAL PROPERTY

 

I.            Copyright Registrations

 

	
 
    	
 
    	
 
    	
 
    	
Registration
    	
 
    	
Expiration
    	
 
    
	
Registered Owner
    	
 
    	
Title
    	
 
    	
Number
    	
 
    	
Date
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
None.
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

II.            Copyright Applications

 

	
 
    	
 
    	
 
    	
 
    	
Registration
    	
 
    	
Date
    	
 
    
	
Registered Owner
    	
 
    	
Title
    	
 
    	
Number
    	
 
    	
Filed
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
None.
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

 

III.          Copyright Licenses

 

	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
Registration
    	
 
    	
Expiration
    	
 
    
	
Licensee
    	
 
    	
Licensor
    	
 
    	
Title
    	
 
    	
Number
    	
 
    	
Date
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
None.
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

IV.          Patents

 

	
 
    	
 
    	
 
    	
 
    	
Registration
    	
 
    	
Expiration
    	
 
    
	
Registered Owner
    	
 
    	
Mark
    	
 
    	
Number
    	
 
    	
Date
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
None.
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

V.            Patent Applications

 

	
 
    	
 
    	
 
    	
 
    	
Registration
    	
 
    	
Date
    	
 
    
	
Registered Owner
    	
 
    	
Mark
    	
 
    	
Number
    	
 
    	
Filed
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
None.
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

VI.           Patent Licenses

 

	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
Registration
    	
 
    	
Expiration
    	
 
    
	
Licensee
    	
 
    	
Licensor
    	
 
    	
Mark
    	
 
    	
Number
    	
 
    	
Date
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
None.
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

VII.          Trademark Registrations

 

	
 
    	
 
    	
 
    	
 
    	
Registration
    	
 
    	
Expiration
    	
 
    
	
Registered Owner
    	
 
    	
Type
    	
 
    	
Number
    	
 
    	
Date
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
None.
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

VIII.        Trademark Applications

 

	
 
    	
 
    	
 
    	
 
    	
Registration
    	
 
    	
Date
    	
 
    
	
Registered Owner
    	
 
    	
Type
    	
 
    	
Number
    	
 
    	
Filed
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
None.
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

2

 

IX.           Trademark Licenses

 

	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
Registration
    	
 
    	
Expiration
    	
 
    
	
Licensee
    	
 
    	
Licensor
    	
 
    	
Type
    	
 
    	
Number
    	
 
    	
Date
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
None.
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00201-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00201-of-00352.parquet"}]]